Adynxx, Inc. (ADYX)
Develops drug treatments using transcription factor technology to reduce pain and inflammation.
$0.00+0.00%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago+0.0%
The outlook
ADYX is trading at its 52-week low with minimal analyst coverage available. The stock sits near the bottom of its recent range, and sentiment leans bearish based on available data. Price movement today is flat.
What’s behind the score
Price trendMixed vs its moving averages
52-week range0% of the way from its 52-week low to high
Market cap
$580
52-wk high
$0.00
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—